-
1
-
-
84857615145
-
Immunotherapy for metastatic melanoma
-
Zito RZ, Kluger HM,: Immunotherapy for metastatic melanoma. J Cell Biochem 2012; 113: 725-734.
-
(2012)
J Cell Biochem
, vol.113
, pp. 725-734
-
-
Zito, R.Z.1
Kluger, H.M.2
-
3
-
-
84874946383
-
Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes
-
Grotz TE, Vaince F, Hieken TJ,: Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes. Melanoma Res 2013; 23: 132-137.
-
(2013)
Melanoma Res
, vol.23
, pp. 132-137
-
-
Grotz, T.E.1
Vaince, F.2
Hieken, T.J.3
-
4
-
-
84864059882
-
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
-
Azimi F, Scolyer RA, Rumcheva P, et al.: Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 2012; 30: 2678-2683.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2678-2683
-
-
Azimi, F.1
Scolyer, R.A.2
Rumcheva, P.3
-
5
-
-
0025757308
-
Spontaneous regression of metastatic melanoma
-
Hurwitz PJ,: Spontaneous regression of metastatic melanoma. Ann Plast Surg 1991; 26: 403-406.
-
(1991)
Ann Plast Surg
, vol.26
, pp. 403-406
-
-
Hurwitz, P.J.1
-
6
-
-
84886943622
-
Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies
-
Lipson EJ,: Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies. Oncoimmunology 2013; 2: e23661-e23663.
-
(2013)
Oncoimmunology
, vol.2
-
-
Lipson, E.J.1
-
7
-
-
84874872137
-
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
-
Frederick DT, Piris A, Cogdill AP, et al.: BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res 2013; 19: 1225-1231.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 1225-1231
-
-
Frederick, D.T.1
Piris, A.2
Cogdill, A.P.3
-
8
-
-
84880294344
-
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
-
Schilling B, Sucker A, Griewank K, et al.: Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Int J Cancer 2013 133: 1653-1663.
-
(2013)
Int J Cancer
, vol.133
, pp. 1653-1663
-
-
Schilling, B.1
Sucker, A.2
Griewank, K.3
-
9
-
-
0016306692
-
Cancer immunotherapy: An overview
-
Morton DL,: Cancer immunotherapy: An overview. Semin Oncol 1974; 1: 297-310.
-
(1974)
Semin Oncol
, vol.1
, pp. 297-310
-
-
Morton, D.L.1
-
10
-
-
3442880743
-
The experimental local therapy of cutaneous metastases of malignant melanoblastomas with cow pox vaccine or colcemid (demecolcine or omaine)
-
Belisario JC, Milton GW,: The experimental local therapy of cutaneous metastases of malignant melanoblastomas with cow pox vaccine or colcemid (demecolcine or omaine). Aust J Dermatol 1961; 6: 113-118.
-
(1961)
Aust J Dermatol
, vol.6
, pp. 113-118
-
-
Belisario, J.C.1
Milton, G.W.2
-
11
-
-
0017890365
-
Chemotherapy for malignant melanoma: A brief review and personal experience
-
Milton GW, McCarthy WH,: Chemotherapy for malignant melanoma: A brief review and personal experience. Aust N Z J Surg 1978; 48: 53-55.
-
(1978)
Aust N Z J Surg
, vol.48
, pp. 53-55
-
-
Milton, G.W.1
McCarthy, W.H.2
-
12
-
-
0016176253
-
BCG immunotherapy of malignant melanoma: Summary of a seven-year experience
-
Morton DL, Eilber FR, Holmes EC, et al.: BCG immunotherapy of malignant melanoma: Summary of a seven-year experience. Ann Surg 1974; 180: 635-643.
-
(1974)
Ann Surg
, vol.180
, pp. 635-643
-
-
Morton, D.L.1
Eilber, F.R.2
Holmes, E.C.3
-
13
-
-
0014665876
-
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease
-
Lewis MG, Ikonopisov RL, Nairn RC, et al.: Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J 1969; 3: 547-552.
-
(1969)
Br Med J
, vol.3
, pp. 547-552
-
-
Lewis, M.G.1
Ikonopisov, R.L.2
Nairn, R.C.3
-
14
-
-
0027788002
-
Pooled analysis of the efficacy of bacille Calmette-Guerin (BCG) immunotherapy in malignant melanoma
-
Tan JK, Ho VC,: Pooled analysis of the efficacy of bacille Calmette-Guerin (BCG) immunotherapy in malignant melanoma. J Dermatol Surg Oncol 1993; 19: 985-990.
-
(1993)
J Dermatol Surg Oncol
, vol.19
, pp. 985-990
-
-
Tan, J.K.1
Ho, V.C.2
-
15
-
-
56849112041
-
Chemoablation of metastatic melanoma using intralesional Rose Bengal
-
Thompson JF, Hersey P, Wachter E,: Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Res 2008; 18: 405-411.
-
(2008)
Melanoma Res
, vol.18
, pp. 405-411
-
-
Thompson, J.F.1
Hersey, P.2
Wachter, E.3
-
16
-
-
0018099610
-
Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: A randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene
-
Cohen MH, Jessup JM, Felix EL, et al.: Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: A randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene. Cancer 1978; 41: 2456-2463.
-
(1978)
Cancer
, vol.41
, pp. 2456-2463
-
-
Cohen, M.H.1
Jessup, J.M.2
Felix, E.L.3
-
17
-
-
34249030031
-
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: Results of a nationwide survey of the German Dermatologic Co-operative Oncology Group
-
Terheyden P, Kortüm AK, Schulze HJ, et al.: Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: Results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. J Cancer Res Clin Oncol 2007; 133: 437-444.
-
(2007)
J Cancer Res Clin Oncol
, vol.133
, pp. 437-444
-
-
Terheyden, P.1
Kortüm, A.K.2
Schulze, H.J.3
-
19
-
-
0027261153
-
Topical immunotherapy of alopecia areata
-
van der Steen PHM,: Topical immunotherapy of alopecia areata. Dermatol Clin 1993; 11: 619-622.
-
(1993)
Dermatol Clin
, vol.11
, pp. 619-622
-
-
Van Der Steen, P.H.M.1
-
20
-
-
0034797071
-
The therapeutic use of topical contact sensitizers in benign dermatoses
-
Buckley DA, Du Vivier AW,: The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol 2001; 145: 385-405.
-
(2001)
Br J Dermatol
, vol.145
, pp. 385-405
-
-
Buckley, D.A.1
Du Vivier, A.W.2
-
21
-
-
0030569365
-
Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts
-
DeLeve LD,: Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts. Mutat Res 1996; 371: 105-108.
-
(1996)
Mutat Res
, vol.371
, pp. 105-108
-
-
Deleve, L.D.1
-
22
-
-
0023205639
-
Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay
-
Wilkerson MG, Connor TH, Henkin J, et al.: Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay. J Am Acad Dermatol 1987; 17: 606-611.
-
(1987)
J Am Acad Dermatol
, vol.17
, pp. 606-611
-
-
Wilkerson, M.G.1
Connor, T.H.2
Henkin, J.3
-
23
-
-
0024405356
-
Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine
-
Harland CC, Saihan EM,: Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine. Lancet 1989; 8660: 445.
-
(1989)
Lancet
, vol.8660
, pp. 445
-
-
Harland, C.C.1
Saihan, E.M.2
-
24
-
-
27844514282
-
Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma
-
Trefzer U, Sterry W,: Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma. Dermatology 2005; 211: 370-371.
-
(2005)
Dermatology
, vol.211
, pp. 370-371
-
-
Trefzer, U.1
Sterry, W.2
-
25
-
-
34147214020
-
Treatment of extensive cutaneous melanoma metastases with topical diphencyprone
-
Damian DL, Thompson JF,: Treatment of extensive cutaneous melanoma metastases with topical diphencyprone. J Am Acad Dermatol 2007; 56: 869-871.
-
(2007)
J Am Acad Dermatol
, vol.56
, pp. 869-871
-
-
Damian, D.L.1
Thompson, J.F.2
-
26
-
-
72449145330
-
Topical diphencyprone immunotherapy for cutaneous metastatic melanoma
-
Damian DL, Shannon KF, Saw RP, et al.: Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australas J Dermatol 2009; 50: 266-271.
-
(2009)
Australas J Dermatol
, vol.50
, pp. 266-271
-
-
Damian, D.L.1
Shannon, K.F.2
Saw, R.P.3
-
27
-
-
80051732230
-
Dramatic regression of cutaneous, nodal and visceral melanoma metastases
-
Damian DL, Saw RPM,: Dramatic regression of cutaneous, nodal and visceral melanoma metastases. J Am Acad Dermatol 2011; 65: 665-666.
-
(2011)
J Am Acad Dermatol
, vol.65
, pp. 665-666
-
-
Damian, D.L.1
Saw, R.P.M.2
-
28
-
-
0027536213
-
Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man
-
Friedli A, Hunziker T, Finkel B, et al.: Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man. Arch Dermatol Res 1993; 285: 1-5.
-
(1993)
Arch Dermatol Res
, vol.285
, pp. 1-5
-
-
Friedli, A.1
Hunziker, T.2
Finkel, B.3
-
29
-
-
36148974772
-
The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans
-
Friedmann PS,: The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br J Dermatol 2007; 157: 1093-1102.
-
(2007)
Br J Dermatol
, vol.157
, pp. 1093-1102
-
-
Friedmann, P.S.1
-
30
-
-
0036385948
-
Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans
-
Damian DL, Halliday GM,: Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002; 28: 34-45.
-
(2002)
Methods
, vol.28
, pp. 34-45
-
-
Damian, D.L.1
Halliday, G.M.2
-
31
-
-
0023882897
-
The validity and practicality of sun-reactive skin types i through VI
-
Fitzpatrick TB,: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1998; 124: 869-871.
-
(1998)
Arch Dermatol
, vol.124
, pp. 869-871
-
-
Fitzpatrick, T.B.1
-
32
-
-
37549019658
-
Prospective study of urticaria after diphencyprone therapy in patients with viral warts
-
Choi JE, Seo SH, Kim IH, et al.: Prospective study of urticaria after diphencyprone therapy in patients with viral warts. Int J Dermatol 2007; 46: 1313-1314.
-
(2007)
Int J Dermatol
, vol.46
, pp. 1313-1314
-
-
Choi, J.E.1
Seo, S.H.2
Kim, I.H.3
-
33
-
-
0036042539
-
Chemoimmunotherapy for melanoma with dacarbazine and 2,4- dinitrochlorobenzene elicits a specific T cell-dependent immune response
-
Wack C, Kirst A, Becker JC, et al.: Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer Immunol Immunother 2002; 51: 431-439.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 431-439
-
-
Wack, C.1
Kirst, A.2
Becker, J.C.3
-
34
-
-
0025807882
-
Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone
-
van der Steen P, van de Kerkhof P, der Kinderen D, et al.: Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone. J Dermatol 1991; 18: 330-333.
-
(1991)
J Dermatol
, vol.18
, pp. 330-333
-
-
Van Der Steen, P.1
Van De Kerkhof, P.2
Der Kinderen, D.3
-
35
-
-
79952113738
-
TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone
-
Martiniuk F, Damian DL, Thompson JF, et al.: TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. J Drugs Dermatol 2010; 9: 1368-1372.
-
(2010)
J Drugs Dermatol
, vol.9
, pp. 1368-1372
-
-
Martiniuk, F.1
Damian, D.L.2
Thompson, J.F.3
-
36
-
-
47649122633
-
Tumor-specific Th17-polarized cells eradicate large established melanoma
-
Muranski P, Boni A, Antony PA, et al.: Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112: 362-373.
-
(2008)
Blood
, vol.112
, pp. 362-373
-
-
Muranski, P.1
Boni, A.2
Antony, P.A.3
-
37
-
-
0346690036
-
Imiquimod in basal cell carcinoma: How does it work
-
Dummer R, Urosevic M, Kempf W, et al.: Imiquimod in basal cell carcinoma: How does it work ? Br J Dermatol 2003; 149: 57-58.
-
(2003)
Br J Dermatol
, vol.149
, pp. 57-58
-
-
Dummer, R.1
Urosevic, M.2
Kempf, W.3
-
38
-
-
84875878203
-
Aldara activates TLR7-independent immune defence
-
Walter A, Schäfer M, Cecconi V, et al.: Aldara activates TLR7-independent immune defence. Nat Commun 2013; 4: 1560.
-
(2013)
Nat Commun
, vol.4
, pp. 1560
-
-
Walter, A.1
Schäfer, M.2
Cecconi, V.3
-
39
-
-
0033859336
-
Topical imiquimod treatment of a cutaneous melanoma metastasis
-
Steinman A, Funk JO, Schuler G, et al.: Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 2000; 43: 555-5556.
-
(2000)
J Am Acad Dermatol
, vol.43
, pp. 555-5556
-
-
Steinman, A.1
Funk, J.O.2
Schuler, G.3
-
40
-
-
0031718107
-
Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma
-
Goring HD, Zierner A, Kroning Y, et al.: Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma. Melanoma Res 1998; 8: 379.
-
(1998)
Melanoma Res
, vol.8
, pp. 379
-
-
Goring, H.D.1
Zierner, A.2
Kroning, Y.3
-
41
-
-
0031422208
-
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma
-
Strobbe LJ, Hart AA, Rumke P, et al.: Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma. Melanoma Res 1997; 7: 507-512.
-
(1997)
Melanoma Res
, vol.7
, pp. 507-512
-
-
Strobbe, L.J.1
Hart, A.A.2
Rumke, P.3
-
42
-
-
0034949014
-
Chemoimmunotherapy for melanoma with dacarbazine and 2,4- dinitrochlorobenzene: Results from a murine tumour model
-
Wack C, Becker JC, Brocker EB, et al.: Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: Results from a murine tumour model. Melanoma Res 2001; 11: 247-253.
-
(2001)
Melanoma Res
, vol.11
, pp. 247-253
-
-
Wack, C.1
Becker, J.C.2
Brocker, E.B.3
|